Recent Blog Articles
Cardiovascular safety from prostate cancer drugs remains uncertain
Rising alcohol use among older adults
Easily distracted? Try meditation
Harvard Health Ad Watch: Can a wearable device reduce stress?
Listening to your hunger cues
Does your child need to bathe every day?
Can flavonoids help fend off forgetfulness?
Can physical or cognitive activity prevent dementia?
Wondering how much your medical care will cost? New rules could help
Long-lasting healthy changes: Doable and worthwhile
Jorg Dietrich, MD, PhD
Contributor
Jorg Dietrich, MD, PhD, MMSc, FANA, FAAN, is the director of the Cancer & Neurotoxicity Clinic and Brain Repair Research Program at the Massachusetts General Hospital (MGH) Cancer Center, associate professor of neurology at Harvard Medical School, and attending physician at MGH.
His clinical interests are management of patients with benign and malignant brain tumors and neurologic complications of cancer therapy, including toxicity from radiation, chemotherapy, and immunotherapies. His research activities include clinical, translational, and basic research in the fields of brain tumor biology, biomarkers of cancer, neurotoxicity from cancer therapies, and brain repair mechanisms.
Dr. Dietrich is the author of over 150 publications, including original research articles, review papers, book chapters, and other scientific contributions. His work has been supported by the National Institute of Health, the American Cancer Society, the American Academy of Neurology, and other foundations.
